Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

Generate:Biomedicines and The University of Texas MD Anderson Cancer Center today announced a strategic collaboration to jointly discover and co-develop protein therapeutics for up to five oncology targets in advanced cancers, including small-cell and non-small-cell lung cancer. Under the co-development…

Read MoreGenerate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

LeanTaaS Earns Highest Ratings in Inaugural KLAS Capacity Optimization Management Report

The market leader in providing AI-powered and SaaS-based capacity management, staffing, and patient flow software for health systems, today announced it has been named the highest, fully-rated company in the first-ever capacity optimization report by KLAS Research. Across LeanTaaS’ large customer…

Read MoreLeanTaaS Earns Highest Ratings in Inaugural KLAS Capacity Optimization Management Report

Surescripts to Present New Data on Opportunities to Expand Access & Fill Gaps in Primary Care and More at NCPDP 2023 Annual Technology & Business Conference

Surescripts, the nation’s leading health information network, will lead two sessions at the National Council for Prescription Drug Programs (NCPDP) Annual Technology & Business Conference on May 9, 2023, on Opportunities to Expand Access & Fill Gaps in Primary Care and Improving Sig Clarity: Tools…

Read MoreSurescripts to Present New Data on Opportunities to Expand Access & Fill Gaps in Primary Care and More at NCPDP 2023 Annual Technology & Business Conference

Nuvo Group Ltd., A Leading FDA-Cleared Innovator in Pregnancy Care, and LAMF Global Ventures Corp I, Led by Chairman Jeffrey Soros and CEO Simon Horsman, Announce Intent to List Nuvo on Nasdaq Through a Business Combination

Nuvo Group Ltd. (“Nuvo” or “the Company”), the creators of INVU by Nuvo™, an FDA-cleared remote pregnancy monitoring platform, and LAMF Global Ventures Corp I (NASDAQ: LGVC) (“LAMF”), a special purpose acquisition company (“SPAC”), today announced that they have entered…

Read MoreNuvo Group Ltd., A Leading FDA-Cleared Innovator in Pregnancy Care, and LAMF Global Ventures Corp I, Led by Chairman Jeffrey Soros and CEO Simon Horsman, Announce Intent to List Nuvo on Nasdaq Through a Business Combination

LE SYSTÈME DE SGC EN TEMPS RÉEL (SGCtr) DEXCOM G6 EST MAINTENANT COUVERT PAR LE PROGRAMME DES SSNA POUR TOUS LES CLIENTS ATTEINTS DE DIABÈTE ADMISSIBLES QUI PRENNENT DE L’INSULINE

Dexcom, Inc. (NASDAQ : DXCM), un chef de file à l’échelle internationale dans le domaine de la surveillance du glucose en continu (SGC) et en temps réel pour les personnes atteintes de diabète, se réjouit de l’élargissement progressif de la…

Read MoreLE SYSTÈME DE SGC EN TEMPS RÉEL (SGCtr) DEXCOM G6 EST MAINTENANT COUVERT PAR LE PROGRAMME DES SSNA POUR TOUS LES CLIENTS ATTEINTS DE DIABÈTE ADMISSIBLES QUI PRENNENT DE L’INSULINE

Global AI-Enabled Medical Imaging Solutions Market Research Report 2023: An $18.356 Billion Market by 2032, Growing at a CAGR of 25.76% – ResearchAndMarkets.com

The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032. The growth in the global AI-enabled medical…

Read MoreGlobal AI-Enabled Medical Imaging Solutions Market Research Report 2023: An $18.356 Billion Market by 2032, Growing at a CAGR of 25.76% – ResearchAndMarkets.com